Akorn appoints 2 executives

Akorn, a leading specialty pharmaceutical company, is welcoming two new executives.

Beth Zelnick Kaufman has joined Akorn as the executive vice president, chief legal officer and corporate secretary.  Sandhya Goyal has joined Akorn as the senior vice president and chief scientific officer.  Both Zelnick Kaufman and Goyal will report to Douglas Boothe, Akorn's president and CEO.

Goyal most recently was the vice president of research and development for Cosette Pharmaceuticals (formerly G&W Labs) and will provide leadership to Akorn's research & development organization.

Zelnick Kaufman will be leading Akorn's legal and compliance and ethics teams after having most recently been the chief legal officer for the Broad Institute of MIT and Harvard.

"I am excited to have two leaders with the breadth of pharmaceutical experience and the functional expertise that Beth and Sandhya are bringing to Akorn at this point in our growth as a company," said  Boothe.